Danone's Open Innovation Model
Danone's Irini Schoeman-Giziakis discusses open innovation, nutrition in the GLP-1 era, and artificial intelligence.
The company is focused on meeting the nutritional needs of people taking GLP-1 drugs or trying to retain weight loss after coming off them.
It's early days, says Irini Schoeman-Giziakis, Danone's open innovation manager.
Danone is considering how to position its existing products, such as Activia, Alpro, Silk, and Evian, to fit the needs of GLP-1 patients, either by labeling them as "GLP-1 friendly" or through nutrition and online shopping apps.
Author's summary: Danone explores open innovation and GLP-1 nutrition.
More News
- An Instant Classic, the 2025 World Series Was a Huge Win for MLB
- techUK’s Autumn 2025 Budget submission
- Home record alive as Phoenix take down Wildcats
- How former Vancouver Canadians performed for the Blue Jays in the World Series
- The wildest fight in UFC history: Cortés-Acosta goes from being finished to finishing Ante Delija
- Pacific Defence Ministers escalate militarisation across the region
- Blood-spattered fox hunting season begins
- €377 billion for weapons–Germany’s most extensive rearmament programme since Hitler